Metropolis Healthcare Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.091x

Metropolis Healthcare Limited cash flow conversion efficiency. Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has a cash flow conversion efficiency ratio of 0.091x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.32 Billion ≈ $14.25 Million USD) by net assets (Rs14.43 Billion ≈ $156.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Metropolis Healthcare Limited (2014–2025)

Cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025. This chart illustrates how Metropolis Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Metropolis Healthcare Limited (METROPOLIS) stock price for real-time trading data and today's change.

Metropolis Healthcare Limited Cash Flow Conversion Ratio Explained

Metropolis Healthcare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Metropolis Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Metropolis Healthcare Limited ranked by their cash flow conversion efficiency. Also see Metropolis Healthcare Limited (METROPOLIS) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sto SE & Co. KGaA F:STO3	0.023x
Dalian Friendship Group Co Ltd SHE:000679	-0.543x
Metropolitan Land Tbk JK:MTLA	0.010x
Ningbo Color Master Batch Co. Ltd. SHE:301019	0.030x
All For One Steeb AG F:A1OS	0.059x
GuangDong GenSho Logistics Co SHG:603813	-0.033x
Haymaker Acquisition Corp. 4 NYSE:HYAC	-0.215x
BH Co Ltd KQ:090460	0.352x

Annual Cash Flow Conversion Efficiency for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025. Review Metropolis Healthcare Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs13.35 Billion ≈ $144.34 Million	Rs2.63 Billion ≈ $28.41 Million	0.197x	-18.05%
2024-03-31	Rs10.99 Billion ≈ $118.88 Million	Rs2.64 Billion ≈ $28.56 Million	0.240x	-3.68%
2023-03-31	Rs9.91 Billion ≈ $107.14 Million	Rs2.47 Billion ≈ $26.72 Million	0.249x	-12.54%
2022-03-31	Rs8.88 Billion ≈ $96.05 Million	Rs2.53 Billion ≈ $27.39 Million	0.285x	-18.92%
2021-03-31	Rs7.08 Billion ≈ $76.57 Million	Rs2.49 Billion ≈ $26.93 Million	0.352x	-14.09%
2020-03-31	Rs5.25 Billion ≈ $56.79 Million	Rs2.15 Billion ≈ $23.25 Million	0.409x	+90.72%
2019-03-31	Rs4.20 Billion ≈ $45.42 Million	Rs901.51 Million ≈ $9.75 Million	0.215x	-11.37%
2018-03-31	Rs4.29 Billion ≈ $46.41 Million	Rs1.04 Billion ≈ $11.24 Million	0.242x	-18.09%
2017-03-31	Rs3.44 Billion ≈ $37.22 Million	Rs1.02 Billion ≈ $11.00 Million	0.296x	-4.95%
2016-03-31	Rs2.94 Billion ≈ $31.78 Million	Rs914.16 Million ≈ $9.89 Million	0.311x	+72.03%
2015-03-31	Rs3.84 Billion ≈ $41.56 Million	Rs694.91 Million ≈ $7.52 Million	0.181x	-25.29%
2014-03-31	Rs3.18 Billion ≈ $34.37 Million	Rs769.22 Million ≈ $8.32 Million	0.242x	--

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research

Market Cap

$313.85 Million

Rs29.02 Billion INR

Market Cap Rank

#14325 Global

#711 in India

Share Price

Rs559.90

Change (1 day)

+2.61%

52-Week Range

Rs421.75 - Rs2050.50

All Time High

Rs3431.71